RecruitingNot ApplicableNCT07070089

BosSTENT ImpLant to trEat debilitatiNg Pulse-synchronous Tinnitus


Sponsor

Sonorous NV, Inc

Enrollment

90 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called BosSTENT implantation for people with pulsatile tinnitus and venous sinus stenosis. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEBosSTENT implantation

BosSTENT implantation in the transverse venous sinus


Locations(6)

The Ottawa Hospital

Ottawa, Canada, Canada

Unity Health Toronto - St. Michael's Hospital

Toronto, Canada, Canada

CHU de Bordeaux

Bordeaux, France, France

CHU Montpelier

Montpellier, France, France

Hôpital de la Pitié Salpêtrière

Paris, France, France

CHRU Tours

Tours, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07070089


Related Trials